
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1088 | 1088 | 1085 | 1065 | 1471 | 1810 |
Fund Return | 8.77% | 8.77% | 8.52% | 2.11% | 8.03% | 6.11% |
Place in category | 96 | 96 | 258 | 316 | 242 | 139 |
% in Category | 15 | 15 | 38 | 56 | 51 | 47 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
VF CH Valiant Swiss Equities SPI I | 554.68M | 8.58 | 1.39 | 5.37 | ||
LO Institutional Strategies CH Swi | 500.02M | 2.49 | 4.23 | 5.13 | ||
LO Institutional Strategies CH Swis | 500.02M | -0.97 | 2.20 | 4.97 | ||
Avadis VermOgensbildung SICAV Strat | 266.17M | -0.87 | 1.40 | 3.41 | ||
CH0364960218 | 255.02M | 6.41 | -1.08 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
CH0033782431 | 2.34B | 9.97 | 4.26 | 6.64 | ||
Pictet CH Institutional Swiss EquiZ | 1.91B | 8.90 | 2.54 | 8.57 | ||
Pictet CH Institutional Swiss EquiI | 1.91B | 6.32 | 1.38 | 6.61 | ||
Pictet CH Institutional Swiss EquiP | 1.91B | 6.27 | 1.17 | 6.39 | ||
Pictet CH Institutional Swiss EquZD | 1.91B | 6.45 | 1.86 | 7.11 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Roche Holding Participation | CH0012032048 | 12.83 | 243.80 | +0.33% | |
Nestle | CH0038863350 | 12.46 | 84.98 | +0.81% | |
Novartis | CH0012005267 | 12.33 | 86.09 | +1.63% | |
Zurich Insurance Group | CH0011075394 | 5.81 | 529.20 | -5.30% | |
Richemont | CH0210483332 | 5.73 | 135.75 | 0.00% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Strong Sell | Sell |
Technical Indicators | Strong Sell | Strong Sell | Sell |
Summary | Strong Sell | Strong Sell | Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review